Company / Working Capital
Insight Molecular Diagnostics Inc. Working Capital History
FY2020-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Working Capital
$3.2M
FY2025
5-year range
$3.2M / $25.0M
FY2021-FY2025
Trend
-27.9%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Working Capital has fluctuated over the past 6 years, ranging from $230,000 in FY2020 to $25M in FY2021.
Based on SEC 10-K filings.
$3M in FY2025 with a 5-year CAGR of +69.6%.
Declined from $4M to $3M over the past 2 years.
Working Capital over time
Growth rates
- 3-Year CAGR
- -37.8%
- 5-Year CAGR
- +69.6%
- 10-Year CAGR
- -
Key checks
Key Insights
- 5-year CAGR of +69.6%, indicating consistent growth.
- In FY2025, working capital decreased 27.9% year-over-year.
- Peak working capital was recorded in FY2021.
- Lowest working capital in the period was in FY2020.
Company context
Key Data Points
- Altman Z-Score -7.34 (distress zone, below 1.8 threshold)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Working CapitalValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $3.2M | -27.9% |
| FY2024 | $4.5M | +28.0% |
| FY2023 | $3.5M | -73.9% |
| FY2022 | $13.4M | -46.3% |
| FY2021 | $25.0M | +10779.6% |
| FY2020 | $230.0K | - |
As of FY2025 · SEC 10-K · Updated Jun 24, 2026